Tigertriever 17 Revascularization Device
Payments companies reported to CMS as associated with Tigertriever 17 Revascularization Device. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tigertriever 17 Revascularization Device, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tigertriever 17 Revascularization Device
These are the largest totals companies reported as associated with Tigertriever 17 Revascularization Device. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Edgar Samaniego | Iowa City, IA | Vascular & Interventional Radiology | $97,565.94 |
| Justin Singer | Grand Rapids, MI | Neurological Surgery | $73,437.57 |
| Rishi Gupta | Marietta, GA | Neurological Surgery | $66,430.26 |
| Erez Nossek | New York, NY | Neurological Surgery | $63,834.54 |
| Shahram Majidi | New York, NY | Neurological Surgery | $43,893.26 |
| Benjamin Yim | Walnut Creek, CA | Neurological Surgery | $34,224.84 |
| Geoffrey Colby | Los Angeles, CA | Neurological Surgery | $30,161.79 |
| Sudhakar Satti | Paoli, PA | Neuroradiology | $28,055.81 |
| Sudipta Roychowdhury | East Brunswick, NJ | Neuroradiology | $24,696.96 |
| Satoshi Tateshima | Los Angeles, CA | Vascular & Interventional Radiology | $20,660.81 |
Prescribed Tigertriever 17 Revascularization Device?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.